SCHEMBL19081879

SCHEMBL19081879

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6c(c5)oc5ccc7sc8c9ccccc9ccc8c7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.38
CYP1B1 Q16678 4/20 0.38
PGR P06401 1/20 0.36
CYP1A2 P05177 3/20 0.36
ABCG2 Q9UNQ0 3/20 0.36
F9 P00740 2/20 0.36
PAX8 Q06710 2/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
LIMK1 P53667 2/20 0.33
HCRTR1 O43613 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
ESR1 P03372 2/20 0.32
ESR2 Q92731 2/20 0.32
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082019 0.98 CYP1A1 (0.38) CYP1A1CYP1B1PGRCYP1A2ABCG2
SCHEMBL19081861 0.89 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081892 0.89 CYP1A1 (0.40) CYP1A1CYP1B1PGRCYP1A2ABCG2
SCHEMBL19081876 0.89 CYP1A1 (0.40) CYP1A1CYP1B1PGRCYP1A2ABCG2
SCHEMBL26492283 0.89 PGR (0.37) CYP1A1PGRCYP1A2ABCG2F9
SCHEMBL19076847 0.88 TDP1 (0.36) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081763 0.87 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19082005 0.87 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2PAX8
SCHEMBL19081986 0.87 ABCG2 (0.36) CYP1A1CYP1B1CYP1A2ABCG2F9
SCHEMBL19081821 0.86 ABCG2 (0.40) CYP1A1CYP1B1CYP1A2ABCG2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885PGR 1721/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885PGR 1721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.